National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022 (No. 2) (Cth)
PB 12 of 2022
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022
(No. 2)
National Health Act 1953
I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 28 February 2022
NIKOLAI TSYGANOV
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Contents
1......... Name............................................................................................................................... 1
2......... Commencement............................................................................................................... 1
3......... Authority......................................................................................................................... 1
4......... Schedules......................................................................................................................... 1
Schedule 1—Amendments 2
National Health (Pharmaceutical benefits—early supply) Instrument 2015
(PB 120 of 2015). 2
Name
(1)This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022 (No. 2).
(2)This Instrument may also be cited as PB 12 of 2022.
Commencement
(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 March 2022 | 1 March 2022 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
Authority
This instrument is made under subsection 84AAA(2) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)
Schedule 1, after entry for Etanercept in the form Injection 50 mg in 1 mL single use auto‑injector, 4
insert:
| Injection 50 mg in 1 mL single use dose-dispenser cartridges, 4 | 20 | 1 | 3 |
| 20 | 1 | 5 |
Schedule 1, entry for Methotrexate
substitute:
| Methotrexate | Injection 7.5 mg in 0.15 mL pre‑filled syringe | 20 | 4 | 5 |
| Injection 10 mg in 0.2 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 15 mg in 0.3 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 20 mg in 0.4 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 25 mg in 0.5 mL pre‑filled syringe | 20 | 4 | 5 |
Schedule 1, after entry for Vismodegib
insert:
| Zanubrutinib | Capsule 80 mg | 20 | 120 | 5 |
0
0
0